Research indicates that dysregulation of lipid metabolism, along with the excessive accumulation of lipids in non-adipose tissues due to the upregulation of srebf1, is implicated in the development of metabolic disorders, including obesity, insulin resistance, and fatty liver disease (40). This evidence concerns the gene SREBF1 and obesity due to melanocortin 4 receptor deficiency.